NHL: As a second-line treatment in phase 3 trial, tisa-cel disappointsDecember 15, 2021Aggressive LymphomasCellular TherapyGene Therapy
Beta-thalassemia gene therapy achieves lasting transfusion independenceDecember 11, 2021Gene TherapyTransfusion MedicineAnemia
Gene therapy effective in hemophilia B patients with neutralizing antibodiesFebruary 14, 2020Bleeding DisordersGene Therapy
LentiGlobin reduces transfusion dependence in young thalassemia patientsMay 3, 2019Bleeding DisordersAnemiaPediatricsGene Therapy
ICYMI: NIH renames, streamlines gene therapy committeeApril 26, 2019Cellular TherapyBusiness of MedicineAnemiaGene Therapy
Gene therapy restored immunity in newly diagnosed SCID-X1April 23, 2019PediatricsCellular TherapyGene Therapy
Barriers to CAR T use in the spotlight at first European meetingFebruary 28, 2019B Cell LymphomaAggressive LymphomasCellular TherapyBusiness of MedicineGene Therapy
CMS proposes coverage of CAR T-cell therapy in trialsFebruary 15, 2019Business of MedicineGene Therapy
